Amplify Treatments, Testing and Advancements ETF (NYSEARCA:GERM) Trading Up 3.4%

Amplify Treatments, Testing and Advancements ETF (NYSEARCA:GERMGet Free Report)’s share price traded up 3.4% during trading on Wednesday . The stock traded as high as $20.20 and last traded at $20.20. 10,340 shares traded hands during mid-day trading, an increase of 357% from the average session volume of 2,261 shares. The stock had previously closed at $19.54.

Amplify Treatments, Testing and Advancements ETF Price Performance

The company has a market capitalization of $10.76 million, a PE ratio of 7.10 and a beta of 1.08. The company’s 50 day simple moving average is $18.21 and its 200 day simple moving average is $18.41.

Amplify Treatments, Testing and Advancements ETF Company Profile

(Get Free Report)

The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group.

Featured Articles

Receive News & Ratings for Amplify Treatments Testing and Advancements ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Treatments Testing and Advancements ETF and related companies with MarketBeat.com's FREE daily email newsletter.